Heterozygous deletions in CFHR3-CFHR1 genes have also been linked to atypical hemolytic uremic syndrome in pediatric ALL patients and transplant-associated thrombotic microangiopathy in neuroblastoma patients [50,51]. The gene discussed is CFHR1; the disease is neuroblastoma.